APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Cancer Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lung Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchLung Cancer Treatment Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Cancer Treatment Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Lung Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Cancer Treatment Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Lung Cancer Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lung Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lung Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung Cancer Treatment Drugs include Sanofi-Aventis, Roche, Eli Lilly and Company, Pfizer, GlaxoSmithKline and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lung Cancer Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lung Cancer Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lung Cancer Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lung Cancer Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lung Cancer Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lung Cancer Treatment Drugs Market by Company

Sanofi-Aventis

Roche

Eli Lilly and Company

Pfizer

GlaxoSmithKline

AstraZeneca

Lung Cancer Treatment Drugs Segment by Type

Chemotherapy

Pipeline Drugs

Targeted Therapies

Lung Cancer Treatment Drugs Segment by Application

Diagnostic Centers

Hospitals

Research Institutes

Others

Lung Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lung Cancer Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lung Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Chemotherapy Table 2. Major Company of Pipeline Drugs Table 3. Major Company of Targeted Therapies Table 4. Global Lung Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Lung Cancer Treatment Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Lung Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Lung Cancer Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Lung Cancer Treatment Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Lung Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Lung Cancer Treatment Drugs Industry Trends Table 26. Lung Cancer Treatment Drugs Industry Drivers Table 27. Lung Cancer Treatment Drugs Industry Opportunities and Challenges Table 28. Lung Cancer Treatment Drugs Industry Restraints Table 29. Global Lung Cancer Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Lung Cancer Treatment Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Lung Cancer Treatment Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Lung Cancer Treatment Drugs Sales Share by Company (2021-2026) Table 33. Global Lung Cancer Treatment Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Lung Cancer Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Lung Cancer Treatment Drugs Major Company Production Sites and Headquarters Table 36. Global Lung Cancer Treatment Drugs Company, Product Type & Application Table 37. Global Lung Cancer Treatment Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Lung Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Lung Cancer Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Lung Cancer Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Lung Cancer Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Lung Cancer Treatment Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Lung Cancer Treatment Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Lung Cancer Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Lung Cancer Treatment Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Lung Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Lung Cancer Treatment Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Lung Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Lung Cancer Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Lung Cancer Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Lung Cancer Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Lung Cancer Treatment Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Lung Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi-Aventis Company Information Table 73. Sanofi-Aventis Business Overview Table 74. Sanofi-Aventis Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi-Aventis Lung Cancer Treatment Drugs Product Portfolio Table 76. Sanofi-Aventis Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Roche Lung Cancer Treatment Drugs Product Portfolio Table 81. Roche Recent Development Table 82. Eli Lilly and Company Company Information Table 83. Eli Lilly and Company Business Overview Table 84. Eli Lilly and Company Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Eli Lilly and Company Lung Cancer Treatment Drugs Product Portfolio Table 86. Eli Lilly and Company Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Lung Cancer Treatment Drugs Product Portfolio Table 91. Pfizer Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Lung Cancer Treatment Drugs Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca Lung Cancer Treatment Drugs Product Portfolio Table 101. AstraZeneca Recent Development Table 102. North America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Lung Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 104. North America Lung Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 105. North America Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Lung Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 107. North America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Lung Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Lung Cancer Treatment Drugs Market Share by Country (2021-2026) Table 110. North America Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Lung Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 112. Europe Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Lung Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 114. Europe Lung Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 115. Europe Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Lung Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Lung Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Lung Cancer Treatment Drugs Market Share by Country (2021-2026) Table 120. Europe Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Lung Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Lung Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Lung Cancer Treatment Drugs Market Share by Country (2021-2026) Table 130. Asia-Pacific Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Lung Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 132. Latin America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Lung Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 134. Latin America Lung Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 135. Latin America Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Lung Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Lung Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Lung Cancer Treatment Drugs Market Share by Country (2021-2026) Table 140. Latin America Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Lung Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Lung Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Lung Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Lung Cancer Treatment Drugs Market Share by Country (2021-2026) Table 150. Middle East and Africa Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Lung Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Lung Cancer Treatment Drugs Distributors List Table 155. Lung Cancer Treatment Drugs Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Lung Cancer Treatment Drugs Image Figure 2. Global Lung Cancer Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Cancer Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Lung Cancer Treatment Drugs Sales (2021-2032) & (K Units) Figure 5. Chemotherapy Image Figure 6. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pipeline Drugs Image Figure 8. Global Pipeline Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Targeted Therapies Image Figure 10. Global Targeted Therapies Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Lung Cancer Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Lung Cancer Treatment Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Lung Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Lung Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Lung Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Lung Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Lung Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Lung Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Lung Cancer Treatment Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Diagnostic Centers Image Figure 26. Global Diagnostic Centers Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Research Institutes Image Figure 30. Global Research Institutes Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Lung Cancer Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Lung Cancer Treatment Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Lung Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Lung Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Lung Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Lung Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Lung Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Lung Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Lung Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Lung Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Lung Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Lung Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Lung Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Lung Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Lung Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Lung Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Lung Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Lung Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Lung Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Lung Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Lung Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Lung Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Lung Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Lung Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Lung Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Lung Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Lung Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Lung Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Lung Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lung Cancer Treatment Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Lung Cancer Treatment Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Chemotherapy
  • Pipeline Drugs
  • Targeted Therapies
Applications
  • Diagnostic Centers
  • Hospitals
  • Research Institutes
  • Others
Companies covered
  • Sanofi-Aventis
  • Roche
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lung Cancer Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lung Cancer Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lung Cancer Treatment Drugs Market by Type
  6. 1.3.1 Chemotherapy
  7. 1.3.2 Pipeline Drugs
  8. 1.3.3 Targeted Therapies
  9. 1.4 Global Lung Cancer Treatment Drugs Market Size by Type
  10. 1.4.1 Global Lung Cancer Treatment Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Lung Cancer Treatment Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Lung Cancer Treatment Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Lung Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Lung Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Lung Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Lung Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Lung Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lung Cancer Treatment Drugs Industry Trends
  2. 2.2 Lung Cancer Treatment Drugs Industry Drivers
  3. 2.3 Lung Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Lung Cancer Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lung Cancer Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Lung Cancer Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Lung Cancer Treatment Drugs Price (2021-2026)
  4. 3.4 Global Lung Cancer Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lung Cancer Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Lung Cancer Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Lung Cancer Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lung Cancer Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lung Cancer Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lung Cancer Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Lung Cancer Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Lung Cancer Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lung Cancer Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Lung Cancer Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lung Cancer Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lung Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lung Cancer Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Lung Cancer Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lung Cancer Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lung Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lung Cancer Treatment Drugs by Application
  1. 5.1 Lung Cancer Treatment Drugs Market by Application
  2. 5.1.1 Diagnostic Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Lung Cancer Treatment Drugs Market Size by Application
  7. 5.2.1 Global Lung Cancer Treatment Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Lung Cancer Treatment Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Lung Cancer Treatment Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Lung Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Lung Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Lung Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Lung Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Lung Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi-Aventis
  2. 6.1.1 Sanofi-Aventis Company Information
  3. 6.1.2 Sanofi-Aventis Business Overview
  4. 6.1.3 Sanofi-Aventis Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi-Aventis Lung Cancer Treatment Drugs Product Portfolio
  6. 6.1.5 Sanofi-Aventis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Lung Cancer Treatment Drugs Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Lung Cancer Treatment Drugs Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Lung Cancer Treatment Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Lung Cancer Treatment Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Lung Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Lung Cancer Treatment Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Lung Cancer Treatment Drugs Sales by Country
  2. 7.1.1 North America Lung Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lung Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lung Cancer Treatment Drugs Market Size by Country
  6. 7.2.1 North America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lung Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lung Cancer Treatment Drugs Sales by Country
  2. 8.1.1 Europe Lung Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lung Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lung Cancer Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lung Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lung Cancer Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Lung Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lung Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lung Cancer Treatment Drugs Sales by Country
  2. 10.1.1 South America Lung Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lung Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lung Cancer Treatment Drugs Market Size by Country
  6. 10.2.1 South America Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lung Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lung Cancer Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Lung Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lung Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lung Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lung Cancer Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Lung Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lung Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lung Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lung Cancer Treatment Drugs Value Chain Analysis
  2. 12.1.1 Lung Cancer Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lung Cancer Treatment Drugs Production Mode & Process
  7. 12.2 Lung Cancer Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lung Cancer Treatment Drugs Distributors
  10. 12.2.3 Lung Cancer Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst